183 related articles for article (PubMed ID: 38927459)
21. Therapeutic Potential of Vital Transcription Factors in Alzheimer's and Parkinson's Disease With Particular Emphasis on Transcription Factor EB Mediated Autophagy.
Rai SN; Tiwari N; Singh P; Mishra D; Singh AK; Hooshmandi E; Vamanu E; Singh MP
Front Neurosci; 2021; 15():777347. PubMed ID: 34970114
[TBL] [Abstract][Full Text] [Related]
22. Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders.
Ramanan VK; Saykin AJ
Am J Neurodegener Dis; 2013 Sep; 2(3):145-75. PubMed ID: 24093081
[TBL] [Abstract][Full Text] [Related]
23. Meeting the Challenge: Using Cytological Profiling to Discover Chemical Probes from Traditional Chinese Medicines against Parkinson's Disease.
Wang C; Yang X; Mellick GD; Feng Y
ACS Chem Neurosci; 2016 Dec; 7(12):1628-1634. PubMed ID: 27736095
[TBL] [Abstract][Full Text] [Related]
24. Modeling the neuroimmune system in Alzheimer's and Parkinson's diseases.
Balestri W; Sharma R; da Silva VA; Bobotis BC; Curle AJ; Kothakota V; Kalantarnia F; Hangad MV; Hoorfar M; Jones JL; Tremblay MÈ; El-Jawhari JJ; Willerth SM; Reinwald Y
J Neuroinflammation; 2024 Jan; 21(1):32. PubMed ID: 38263227
[TBL] [Abstract][Full Text] [Related]
25. Inflammation and Brain Structure in Alzheimer's Disease and Other Neurodegenerative Disorders: a Mendelian Randomization Study.
Liu WS; Zhang YR; Ge YJ; Wang HF; Cheng W; Yu JT
Mol Neurobiol; 2024 Mar; 61(3):1593-1604. PubMed ID: 37736795
[TBL] [Abstract][Full Text] [Related]
26. Glutamate Receptor Dysregulation and Platelet Glutamate Dynamics in Alzheimer's and Parkinson's Diseases: Insights into Current Medications.
Gautam D; Naik UP; Naik MU; Yadav SK; Chaurasia RN; Dash D
Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002291
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
28. Resistance, vulnerability and resilience: A review of the cognitive cerebellum in aging and neurodegenerative diseases.
Liang KJ; Carlson ES
Neurobiol Learn Mem; 2020 Apr; 170():106981. PubMed ID: 30630042
[TBL] [Abstract][Full Text] [Related]
29. Review of Amyotrophic Lateral Sclerosis, Parkinson's and Alzheimer's diseases helps further define pathology of the novel paradigm for Alzheimer's with heavy metals as primary disease cause.
Cavaleri F
Med Hypotheses; 2015 Dec; 85(6):779-90. PubMed ID: 26604027
[TBL] [Abstract][Full Text] [Related]
30. Potential Use of the Cholesterol Transfer Inhibitor U18666A as a Potent Research Tool for the Study of Cholesterol Mechanisms in Neurodegenerative Disorders.
Yasamineh S; Mehrabani FJ; Derafsh E; Danihiel Cosimi R; Forood AMK; Soltani S; Hadi M; Gholizadeh O
Mol Neurobiol; 2024 Jun; 61(6):3503-3527. PubMed ID: 37995080
[TBL] [Abstract][Full Text] [Related]
31. Novel Trimodal MALDI Imaging Mass Spectrometry (IMS3) at 10 μm Reveals Spatial Lipid and Peptide Correlates Implicated in Aβ Plaque Pathology in Alzheimer's Disease.
Kaya I; Brinet D; Michno W; Başkurt M; Zetterberg H; Blenow K; Hanrieder J
ACS Chem Neurosci; 2017 Dec; 8(12):2778-2790. PubMed ID: 28925253
[TBL] [Abstract][Full Text] [Related]
32. Antidiabetic agents as a novel treatment for Alzheimer's and Parkinson's disease.
Nowell J; Blunt E; Gupta D; Edison P
Ageing Res Rev; 2023 Aug; 89():101979. PubMed ID: 37328112
[TBL] [Abstract][Full Text] [Related]
33. Cell penetrable, clickable and tagless activity-based probe of human cathepsin L.
Dana D; Garcia J; Bhuiyan AI; Rathod P; Joo L; Novoa DA; Paroly S; Fath KR; Chang EJ; Pathak SK
Bioorg Chem; 2019 Apr; 85():505-514. PubMed ID: 30802807
[TBL] [Abstract][Full Text] [Related]
34. Single-cell and single-nuclei RNA sequencing as powerful tools to decipher cellular heterogeneity and dysregulation in neurodegenerative diseases.
Cuevas-Diaz Duran R; González-Orozco JC; Velasco I; Wu JQ
Front Cell Dev Biol; 2022; 10():884748. PubMed ID: 36353512
[TBL] [Abstract][Full Text] [Related]
35. Neurodegenerative Disorders of Alzheimer, Parkinsonism, Amyotrophic Lateral Sclerosis and Multiple Sclerosis: An Early Diagnostic Approach for Precision Treatment.
Pathak N; Vimal SK; Tandon I; Agrawal L; Hongyi C; Bhattacharyya S
Metab Brain Dis; 2022 Jan; 37(1):67-104. PubMed ID: 34719771
[TBL] [Abstract][Full Text] [Related]
36. Shared cerebral metabolic pathology in non-transgenic animal models of Alzheimer's and Parkinson's disease.
Barilar JO; Knezovic A; Perhoc AB; Homolak J; Riederer P; Salkovic-Petrisic M
J Neural Transm (Vienna); 2020 Feb; 127(2):231-250. PubMed ID: 32030485
[TBL] [Abstract][Full Text] [Related]
37. Targeting chaperones, heat shock factor-1, and unfolded protein response: Promising therapeutic approaches for neurodegenerative disorders.
Bose S; Cho J
Ageing Res Rev; 2017 May; 35():155-175. PubMed ID: 27702699
[TBL] [Abstract][Full Text] [Related]
38. Role of Specialized Pro-resolving Mediators in Reducing Neuroinflammation in Neurodegenerative Disorders.
Ponce J; Ulu A; Hanson C; Cameron-Smith E; Bertoni J; Wuebker J; Fisher A; Siu KC; Marmelat V; Adamec J; Bhatti D
Front Aging Neurosci; 2022; 14():780811. PubMed ID: 35250536
[TBL] [Abstract][Full Text] [Related]
39. A Small-Molecule Ratiometric Photoacoustic Probe for the High-Spatiotemporal-Resolution Imaging of Copper(II) Dynamics in the Mouse Brain.
Jiang Z; Zhang C; Wang X; Ling Z; Chen Y; Guo Z; Liu Z
Angew Chem Int Ed Engl; 2024 Mar; 63(13):e202318340. PubMed ID: 38303099
[TBL] [Abstract][Full Text] [Related]
40. Exploring the Potential of Aptamers in Targeting Neuroinflammation and Neurodegenerative Disorders: Opportunities and Challenges.
Kong AH; Wu AJ; Ho OK; Leung MM; Huang AS; Yu Y; Zhang G; Lyu A; Li M; Cheung KH
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
